Benjamin L. Maughan
Professor
Department of Oncological Sciences
Huntsman Cancer Institute
United States of America
Biography
Benjamin Maughan MD, PharmD is an Instructor in the Division of Medical Oncology at Huntsman Cancer Institute specializing in genitourinary malignancies. Dr. Maughan completed his PharmD, cum laude, from Idaho State University in 2004, then completed an oncology pharmacy residency at Mountain States Tumor Institute in 2005. Dr. Maughan earned his MD, cum laude, from the University of Kentucky, College of Medicine in 2010. He finished his Internal Medicine residency training with the University of Utah in 2013 and subsequently completed his medical oncology fellowship at Johns Hopkins in 2016. Dr. Maughan has clinical and research interests in all genitourinary oncology. He recently has been focused on metastatic prostate cancer specifically studying the role of resistance pathways including expression of truncated androgen receptors (ex. AR-V7 expression) and loss of tumor suppressors such as PTEN and Rb. Additionally, he has been focused on studying the relative efficacy of different treatments in prostate cancer to identify optimal treatment sequences for this disease.
Research Interest
Genitourinary Cancers Prostate Cancer
Publications
-
Maughan BL, Xhou XC, Suzman DL, Nadal R, Bassi S, Schweizer MT, Antonarakis ES (2015). Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer. Prostate, 75(15), 1814-20.
-
Maughan BL, Suzman DL, Luber B, Wang H, Glavaris S, Hughes R, Sullivan R, Harb R, Boudadi K, Paller C, Eisenberger M, Demarzo A, Ross A, Antonarakis ES (2016). Pharmacodynamic study of the oral hedgehog pathway inhibitor, vismodegib, in patients with metastatic castration-resistant prostate cancer. (Epub ahead of print) Cancer Chemother Pharmacol.
-
Maughan BL, Luber B, Nadal R, Antonarakis ES (2017). Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Study. Prostate, 77(1), 33-40.
